A novel TLR4-binding peptide that inhibits LPS-induced activation of NF-κB and in vivo toxicity

European Journal of Pharmacology

Volumn 594, Issue 1-3, 2008, Pages 152-156

  Sugiyama, Kei ichi ^a   Muroi, Masashi ^a   Tanamoto, Ken ichi ^a  

^a NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

Author keywords

Endotoxin shock; Lipopolysaccharide; Toll like receptor 4; Yeast two hybrid

Indexed keywords

BINDING PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; PEPTIDE DERIVATIVE; STM 28; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 9; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INTERACTION; CONTROLLED STUDY; CYTOKINE RELEASE; HUMAN; HUMAN CELL; IN VIVO STUDY; LETHALITY; MACROPHAGE; MALE; MAMMAL CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEPTIC SHOCK; TWO HYBRID SYSTEM; YEAST CELL;

BIOTIN; CELL LINE; DOSE-RESPONSE RELATIONSHIP, DRUG; EXTRACELLULAR FLUID; GALACTOSAMINE; HUMANS; LIPOPOLYSACCHARIDES; MACROPHAGES; NF-KAPPA B; PEPTIDES; SACCHAROMYCES CEREVISIAE; SHOCK, SEPTIC; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR-ALPHA;

EID: 50549084162     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2008.07.037     Document Type: Article

References (20)

1. Akira S., Uematsu S., and Takeuchi O. Pathogen recognition and innate immunity. Cell 124 (2006) 783-801
2. Baue A.E. MOF/MODS, SIRS: an update. Shock 6 (1996) S1-S5
3. Bernard G.R., Vincent J.L., Laterre P.F., LaRosa S.P., Dhainaut J.F., Lopez-Rodriguez A., Steingrub J.S., Garber G.E., Helterbrand J.D., Ely E.W., and Fisher Jr. C.J. Recombinant human protein C Worldwide Evaluation in Severe sepsis (PROWESS) study group, efficacy and safety of recombinant human activated protein C for severe sepsis. N. Engl. J. Med. 344 (2001) 699-709
4. Bochud P.Y., and Calandra T. Pathogenesis of sepsis: new concepts and implications for further treatment. BMJ 326 (2006) 262-266
5. da Silva Correia J., Soldau K., Christen U., Tobias P.S., and Ulevitch R.J. Lipopolysaccharide is in close proximity to each of the proteins in its membrane receptor complex. transfer from CD14 to TLR4 and MD-2. J. Biol. Chem. 276 (2001) 21129-21135
6. Doyle S.L., and O'Neill L.A. Toll-like receptors: from discovery of NF-κB to new insights into transcriptional regulations in innate immunity. Biochem. Pharmacol. 72 (2006) 1102-1113
7. Galanos C., Freudenberg M.A., and Reutter W. Galactosamine-induced sensitization to the lethal effects of endotoxin. Proc. Natl. Acad. Sci. U. S. A. 76 (1979) 5939-5943
8. Hack C.E., Aarden L.A., and Thijs L.G. Role of cytokines in sepsis. Adv. Immunol. 66 (1997) 101-195
9. Hong C.-C., Shimomura-Shimizu M., Muroi M., and Tanamoto K. Effect of endocrine disrupting chemicals on lipopolisaccharide-induced TNF-α and nitric oxide production by mouse macrophages. Biol. Pharm. Bull. 27 (2004) 1136-1139
10. Hoshino K., Takeuchi O., Kawai T., Sanjo H., Takada H., Ogawat T., Takeda K., and Akira S. Cutting edge: Toll-like receptor-4(TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J. Immunol. 162 (1999) 3749-3752
11. Hurley J.C. Endotoxemia: methods of detection and clinical correlates. Clin. Microbiol. Rev. 8 (1995) 268-292
12. Kobayashi M., Saito S., Tanimura N., Takahashi K., Kawasaki K., Nishijima M., Fujimoto Y., Fukase K., Akashi-Takamura S., and Miyake K. Regulatory roles for MD-2 and TLR4 in ligand-induced receptor clustering. J. Immunol. 176 (2006) 6211-6218
13. McGettrick A.F., Brint E.K., Palsson-McDermott E.M., Rowe D.C., Golenbock D.T., Gay N.J., Fitzgerald K.A., and O'Neill L.A. Trif-related adapter molecule is phosphorylated by PKCε during Toll-like receptor 4 signaling. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 9196-9201
14. Muroi M., Ohnishi T., and Tanamoto K. Regions of the mouse CD14 molecule required for Toll-like receptor 2- and 4-mediated activation of NF-κB. J. Biol. Chem. 277 (2002) 42372-42379
15. Nagaoka I., Hirota S., Niyonsaba F., Hirata M., Adachi Y., Tamura H., Tanaka S., and Heumann D. Augmentation of the lipopolysaccharide-neutralizing activities of human cathelicidin CAP18/LL-37-derived antimicrobial peptides by replacement with hydrophobic and cationic amino acid residues. Clin. Diagn. Lab. Immunol. 9 (2002) 972-982
16. 114 of human MD-2 are required for Toll-like receptor 4-mediated activation of NF-κB by lipopolisaccharide. J. Immunol. 167 (2001) 3354-3359
17. Poltorak A., He X., Smirnova I., Liu M.Y., Van Huffel C., Du X., Birdwell D., Alejos E., Silva M., Galanos C., Freudenberg M., Ricciardi-Castagnoli P., Layton B., and Beutler B. Defective Lps signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in TLR4 gene. Science 282 (1998) 2085-2088
18. Riedemann N.C., Guo R.F., and Ward P.A. Novel strategies for the treatment of sepsis. Nat. Med. 9 (2003) 517-524
19. Tanamoto K. Induction of lethal shock and tolerance by Porphyromonas gingivalis lipopolisaccharide in d-galactosamine-sensitized C3H/HeJ mice. Infect. Immun. 67 (1999) 3399-3402
20. Yang Q.W., Mou L., Lv F.L., Zhu P.F., Wang Z.G., Jiang J.X., and Wang J.Z. Novel TLR4-antagonizing peptides inhibit LPS-induced release of inflammatory mediators by monocytes. Biochem. Biophys. Res. Commun. 329 (2005) 846-854